Advertisements

Ферроплекс

Quick links to important sections

Ферроплекс

Selected form

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Ферроплекс

What is Ферроплекс? The Core Definition and Class

Property Description
Active Ingredients Ferrous sulfate; Ascorbic acid (Vitamin C)
Form Oral (Coated tablets/dragees)
Pharmacological Class Stimulator of Hematopoiesis; Iron Supplement with Vitamin C
Common Use Treating and preventing iron-deficiency anemia
Origin Synthetic (Chemically synthesized components)

Ферроплекс (Ferroplex) is a combined antianemia preparation that belongs to the pharmacological class of hematinics. It is used therapeutically to treat and prevent conditions related to low iron stores. This particular formulation is commonly supplied as a coated tablet or dragée for oral administration. The drug’s main therapeutic role is to supply the body with elemental iron, a mineral essential for the production of oxygen-carrying hemoglobin.

Composition and Brand Differentiation

This specific brand formulation contains two primary active ingredients: Ferrous sulfate and Ascorbic acid (Vitamin C). The components are synthetic, produced through chemical synthesis for pharmaceutical use. The inclusion of Ascorbic acid is a purposeful feature designed to enhance the absorption of the iron compound from the gut into the bloodstream, thereby improving therapeutic efficiency. This combined action is a standard approach for oral iron supplementation.

General Therapeutic Purpose

The general purpose of Ферроплекс is the restoration of normal iron status in patients diagnosed with iron deficiency, which includes states of latent deficiency or established iron-deficiency anemia. Iron is a vital trace element necessary for many physiological processes, including energy metabolism and immune function. By providing a readily available and easily absorbable source of iron, the medicine aims to help normalize blood cell indices and rebuild the body’s iron reserves, particularly when dietary measures alone are insufficient.

Regulatory References

  1. NIH MedlinePlus Iron Supplements
Advertisements

What side effects are possible with Ферроплекс?

Possible Side Effects and Safety Information

Ferroplex is a combination preparation of Ferrous Sulfate and Ascorbic Acid (Vitamin C), primarily used to treat and prevent iron deficiency anemia. Like all medicines, it can cause side effects, though not everyone experiences them. The most common side effects are typically related to the gastrointestinal system.


Common Side Effects

The iron component often leads to the following temporary effects:

System/Area Effect
Gastrointestinal Nausea or vomiting, abdominal discomfort, diarrhea, or constipation.
Stool Color Darkening or black discoloration of the stool, which is harmless and expected due to unabsorbed iron.

Taking the medication with or just after a meal may help reduce stomach upset. Increasing dietary fiber and fluid intake can help manage constipation.


Important Safety Warnings

  • Accidental Overdose: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. Keep Ferroplex and all iron supplements out of the reach of children. In case of a suspected overdose, seek emergency medical attention immediately.
  • Contraindications: Ferroplex should not be taken by patients with known hypersensitivity to the components, or those with conditions involving iron overload, such as hemochromatosis or hemosiderosis. It is also typically avoided in patients with certain types of anemia, like hemolytic anemia, or active gastrointestinal issues such as peptic ulcers or ulcerative colitis.
  • Drug Interactions: Iron supplements can decrease the absorption of certain other medications, including some antibiotics (e.g., tetracyclines, quinolones), thyroid medications (e.g., levothyroxine), and bisphosphonates. It is crucial to inform your healthcare provider of all current medications to check for potential interactions.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with iron-containing preparations like Ферроплекс (Ferrous Sulfate/Ascorbic Acid) is considered a medical emergency, according to official regulatory information. Management of overdose must be guided by immediate professional medical advice.

Documented Manifestations and Outcomes

Overdose symptoms are often described in stages, beginning with severe gastrointestinal distress. Documented clinical manifestations include:

  • Early Symptoms: Nausea, vomiting (which may contain blood, known as hematemesis), severe abdominal pain, and bloody diarrhea.
  • Severe Complications: Untreated or massive iron overdose can progress to life-threatening systemic effects, including metabolic acidosis, cardiovascular collapse (shock), and serious central nervous system issues such as coma or convulsions.
  • Delayed Effects: Hepatotoxicity, or liver damage, is a potential severe outcome that may manifest later.

Mandatory Emergency Actions

The official prescribing information explicitly mandates the following actions in case of a suspected or confirmed overdose:

  • Immediate Medical Attention Required: If an overdose is suspected, immediate medical attention must be sought without delay, regardless of the severity of initial symptoms.
  • Antidote: The specific agent cited for use in severe iron intoxication is the chelating agent Deferoxamine.
  • Monitoring: Hospital monitoring is required, particularly to observe for the onset of delayed or progressive systemic toxicity.

Population-Specific Risk

Regulators emphasize that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under the age of six. Therefore, all suspected ingestions in this population should be treated as potentially life-threatening and require urgent intervention.

Advertisements

Therapeutic Uses of Ферроплекс

What Ферроплекс Treats: Main Uses and Benefits

The primary therapeutic benefit of Ферроплекс may assist in addressing the underlying systemic imbalance of iron, providing essential nutritional support relevant for overall well-being. Iron is a necessary component to help produce healthy red blood cells.

This preparation is commonly used for managing iron-deficiency anemia (IDA) and the precursor state of latent iron deficiency. It is relevant in conditions characterized by periods of heightened symptoms resulting from nutritional insufficiency, chronic blood loss, or increased physiological demands during pregnancy and lactation. The medicine supports the body in replenishing iron reserves, thereby assisting with maintaining functional stability.

The treatment is applied to manage symptoms related to physical discomfort caused by iron deficiency, particularly chronic fatigue, generalized weakness, and persistent low energy that interfere with daily functioning. By helping to correct the deficiency, this approach generally contributes to easing the overall symptom load. This supports patients during episodes of heightened discomfort by easing distress, and assists with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Relief for Fatigue
This medication is applied to address symptoms that create noticeable physiological strain linked to depleted iron status, which commonly manifest as generalized fatigue and low physical endurance.

Regulatory References

  1. MedlinePlus Medical Encyclopedia
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ферроплекс — official regulatory information


Eligibility scope

Populations for whom use is allowed (as stated in label): Use is generally allowed for adult patients with confirmed iron deficiency anemia.

Populations for whom use is not recommended (if applicable): Use is not recommended for children under the age of 12 years. Caution is advised for patients with a history of stomach or duodenal ulcers.

Populations for whom use is contraindicated: Contraindicated in individuals with documented hypersensitivity to the drug components; those with iron overload conditions, including hemosiderosis or hemochromatosis; and patients with anemias not caused by iron deficiency, such as aplastic anemia, hemolytic anemia, or thalassemia, due to a lack of proper iron utilization.

Age-related eligibility rules: Contraindicated for use in children under 12 years of age. Pediatric use has specific restrictions.

Condition-specific eligibility rules: Contraindicated in conditions involving impaired iron utilization, such as sideroachrestic anemia, and in patients following gastric resection.

Pregnancy and lactation eligibility status (if explicitly documented): Use is only permitted with caution during pregnancy and lactation. This status requires explicit medical consideration.

Eligibility-related restrictions: Prohibited in patients with active gastrointestinal bleeding.


Eligibility classifications (high-level)

Eligibility severity classification (as defined in official documents): Contraindicated for iron overload and specific anemias; Caution for ulcers and specific age groups.

Regulatory basis (EMA / FDA / etc.): Based on authorized national regulatory documents (e.g., Eastern European/CIS regulatory labeling).

Eligibility-context constraints (as defined in official documents): Restrictions are primarily tied to existing iron-status disorders and certain gastrointestinal conditions.


Resulting eligibility structure

Official eligibility statements:

  • The drug is formally contraindicated in patients with conditions that result in excess iron accumulation, such as hemochromatosis and hemosiderosis.
  • It is not to be used by patients whose anemia is a result of impaired iron utilization, including aplastic or hemolytic anemias.
  • Use is contraindicated in children younger than 12 years of age.

Connection to the overall eligibility profile (2–4 sentences): The regulatory documents define who can and cannot use the medicine by strictly restricting its use to individuals with proven iron deficiency. Use is prohibited when the patient has a pre-existing condition causing iron overload or when the patient’s anemia is caused by a failure to utilize iron, rather than a simple deficiency. Specific warnings are also provided regarding age and prior surgical history, ensuring the drug is only administered when the underlying cause is a lack of iron. The most severe eligibility restriction is the formal contraindication for patients under 12 years old.

Advertisements

What should I know about interactions with other medicines?

The iron component in Ферроплекс (Ferrous gluconate) can significantly alter the absorption of numerous co-administered medicinal products, primarily by forming insoluble complexes (chelation) in the gastrointestinal tract. This can lead to a reduced concentration of the interacting drug in the bloodstream and potentially diminish its therapeutic effect.

Key interaction categories and specific medicines that require management are:

Interacting Product Category Effect on Drug Levels Management Principle
Antibiotics (Tetracyclines, Fluoroquinolones like ciprofloxacin) Decreased antibiotic and iron absorption Separate administration
Antacids, PPIs, H2-blockers (e.g., omeprazole, cimetidine) Decreased iron absorption Separate administration
Thyroid Hormones (e.g., levothyroxine) Decreased hormone absorption Separate administration
Bisphosphonates (e.g., alendronic acid) Decreased bisphosphonate absorption Separate administration
Parkinson's Agents (Levodopa, Carbidopa) Decreased agent absorption Separate administration
Polyvalent Cations (e.g., Calcium, Zinc supplements) Decreased iron absorption Separate administration

To minimize these interactions, it is typically necessary to administer Ферроплекс at least 2 hours before or after the interacting medicine. For highly susceptible agents such as certain antibiotics or chelating agents like deferiprone, a separation of 4 to 6 hours may be required. Consultation with a healthcare provider is essential to determine the specific timing constraints for all concurrent therapies.

Advertisements

Mechanism of Action

Optimizing Iron Bioavailability through Chemical Synergy

The initial action of Ферроплекс begins with the chemical facilitation provided by Ascorbic acid. This component functions as a reducing agent, converting insoluble ferric iron ( Fe^3+) into the readily absorbed ferrous form ( Fe^2+) within the small intestine. This synergy supports high substrate availability of the correct iron valence for subsequent absorption by specialized cell-surface transporters.


Transport and Reconstitution of Synthesis Pathways

Following chemical preparation, the Fe^2+ form undergoes active transport across the duodenal lining via the Divalent Metal Transporter 1 (DMT1). Once absorbed, iron is bound to the carrier protein Transferrin and delivered to utilization sites, primarily the bone marrow. Here, the delivered iron is integrated into the Hemoglobin protein, enabling the reconstitution of oxygen-carriage proteins. Simultaneously, iron replenishes essential cofactor stores (like cytochromes), which supports mitochondrial electron transport and cellular energy generation.

Advertisements

Dosage and Administration Information

How to use Ферроплекс

The usage of Ферроплекс (Ferrous sulfate and Ascorbic acid) involves standardized administration parameters. The primary delivery method is oral.

Standard Dosing Regimens

For therapeutic use in addressing established iron deficiency, the adult regimen typically involves taking one tablet two to three times daily. For prophylactic use or prevention, the regimen is generally one tablet taken once daily. For children aged 6 to 12 years, administration is weight-adjusted, and the tablet form is generally reserved for use in children over 6 years of age.


Administration and Timing

The tablets must be swallowed whole with water. They are not to be sucked, chewed, or held in the mouth, as this restriction is necessary for proper drug delivery. Administration can occur either before meals or with meals, depending on gastrointestinal tolerance, although taking the preparation with food may influence the rate of iron absorption.

A specific timing requirement involves taking the medicine at least two hours apart from certain other substances, such as specific antacids or calcium-containing products, to prevent a reduction in iron availability.

Course Duration

The treatment course is designed to replenish the body's iron stores. Use typically continues for a period spanning two to three months after blood indices have returned to normal values.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ферроплекс

Evidence for use in Iron Deficiency Anemia

The core research for Ферроплекс (Ferrous Sulfate and Ascorbic Acid) was studied for use in individuals with iron deficiency anemia. Studies, including Randomized Controlled Trials (RCTs), research examined short-term and intermediate-term changes related to this condition. Researchers were primarily interested in measuring key blood markers, such as hemoglobin (related to oxygen transport) and ferritin (a measure of iron stores).

Findings describe patterns observed in the studies where laboratory values for hemoglobin and ferritin were measured to be different from their starting levels during the defined study periods. Study results reflect the specific conditions under which they were conducted, and findings describe group patterns, not personal outcomes. What is still uncertain is the required duration of use or the specific dose adjustments that may be needed based on individual factors. Comparative evidence is lacking against some of the newer or specialized forms of iron replacement.

Evidence for Prophylaxis of Iron Deficiency (Prevention)

Research has explored the use of this supplement combination for the prevention (prophylaxis) of iron deficiency in people considered to be at a higher risk, such as pregnant women. Studies monitored how the incidence of developing iron deficiency was observed in these at-risk groups. Research examined the outcomes related to maintaining iron status across the monitored duration. However, data for certain groups remain insufficient, and follow-up durations were limited in some prevention trials.

Long-Term Studies and Durability of Follow-up

Many studies explored short-term shifts in measured iron levels, but long-term effects are not fully established. There is limited information for long-term outcomes, especially regarding the durability of iron stores once a person stops using the supplement combination. The follow-up durations were limited in many initial effectiveness trials, and currently, long-term data for stability and maintenance are not well characterized.

What is Still Uncertain About the Research for Ферроплекс

Comparative evidence is lacking against all currently available oral and intravenous iron treatments. Data are still emerging for certain groups, and long-term effects are not fully established. The evidence contributes to the broader evidence landscape but highlights what is known—and what is still uncertain—about this common supplement combination.

Key Studies & References Effectiveness of oral iron supplementation for iron deficiency in non-pregnant adults: A systematic review and meta-analysis

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ферроплекс (FAQ)

Q: How quickly does Ферроплекс start working?

Official treatment guidelines indicate that iron supplementation is continued for a period, typically spanning two to three months, after a patient's blood indices have returned to their normal values. This duration is defined by the goal of fully replenishing the body's iron stores. Changes in important laboratory markers, such as hemoglobin and ferritin, are assessed by healthcare providers over this time frame.

Q: Is Ферроплекс safe for pregnant women, based on official information?

Regulatory information for this type of iron supplement states that its use is generally acceptable during both pregnancy and lactation. Regulatory documents indicate that iron supplementation is often used to manage or prevent iron deficiency in these groups. However, official product information indicates that use is only permitted with caution and requires explicit medical consideration.

Q: Can children use Ферроплекс?

Official regulatory documents clearly state that this product is formally contraindicated (should not be used) in children under 12 years of age. For children aged 6 to 12 years, prescribing information only specifies potential weight-adjusted administration for the tablet form. However, use in this age group is restricted and requires explicit medical supervision, as noted in the official regulatory documents.

Q: Is it necessary to avoid dairy products when taking Ферроплекс?

Administration advice for oral iron supplements states that certain foods, including dairy products, may interfere with iron absorption due to their calcium content. To minimize the potential reduction in iron availability, regulatory information recommends separating administration from interacting substances by at least two hours.

Q: Why is Vitamin C sometimes combined with iron in supplements like Ферроплекс?

The Ascorbic acid (Vitamin C) component is included specifically to help increase the absorption of iron. It works chemically by ensuring the iron is in the particular form ( Fe^2+) that the body is more readily able to absorb through the small intestine. This is a standard, clinically supported approach for oral iron supplementation.

Q: Is Ферроплекс available over the counter or is it prescription only?

Ferrous sulfate preparations are commonly available as a non-prescription (over-the-counter) product. However, some specific formulations or higher doses may require a prescription. Official labeling states that use is advised under the supervision of a physician.

Q: Does Ферроплекс help with low energy levels?

The therapeutic purpose of the medicine is the restoration of normal iron status, a process central to many body functions. Iron is required for the production of oxygen-carrying hemoglobin and the support of cellular energy generation pathways.

Q: How long can a person typically take Ферроплекс?

The duration of treatment is defined by the goal of fully replenishing iron stores. Official instructions specify that use should continue for a period, typically spanning two to three months, after the patient's blood indices have already returned to their normal values.

Q: Is there any research on long-term use of Ферроплекс?

Research overviews indicate that while many studies have examined short-term effects and intermediate changes in blood markers, long-term effects are not fully established. There is limited available information regarding the long-term outcomes and the durability of iron stores once a person stops using the supplement.

Q: Can I take Ферроплекс if I am already taking vitamins?

Regulatory documents note that iron can decrease the absorption of other products. Specifically, Polyvalent Cations (like Calcium or Zinc supplements, which are common vitamin components) require caution and an administration separation of at least two hours to minimize potential interaction.

Q: Is there a different form of Ферроплекс for people who have trouble swallowing pills?

While the Ферроплекс product is provided as a coated tablet, similar iron supplement products containing Ferrous Sulfate are also available in alternative regulatory-approved forms, such as liquid drops or solutions. These alternative forms may be easier for some patients to administer.

Q: Is Ферроплекс suitable for older adults?

Official prescribing documents for iron supplements indicate that the usual adult dose can generally be administered to older adults (elderly). Restrictions may apply based on contraindications related to existing health conditions, as defined in official documents.

Q: What is the difference between Ферроплекс and other popular iron medicines?

Ферроплекс is formally classified as a combined antianemia preparation because it contains two active ingredients: Ferrous sulfate (the iron source) and Ascorbic acid (Vitamin C). Other iron medicines may differ by using a different form of iron salt or by not including Vitamin C in their formulation.

Q: Can Ферроплекс be taken on an empty stomach?

Official guidance states that administration may occur either before meals or with meals, a decision often based on gastrointestinal tolerance. While taking it with food may help reduce stomach upset, iron is generally noted to be more readily absorbed when taken on an empty stomach.

Q: Is the strength of Ферроплекс a standard dose?

The dosage strength is defined by the amount of elemental iron it provides. A dose of 65 mg of elemental iron (the most common strength) is a frequently referenced standard for oral iron supplementation that is often listed in regulatory product information.

Q: Does Ферроплекс contain any ingredients that might cause an allergic reaction?

The medicine is contraindicated in patients with a known hypersensitivity (severe allergic reaction) to its components. The product contains both active ingredients and inactive ingredients (excipients), either of which can potentially cause rare allergic reactions in susceptible individuals. The full list of inactive ingredients is detailed in the official product label.

Q: Are there different dosages of Ферроплекс available?

The dosing regimens for Ферроплекс specify different frequency (e.g., one to three times daily) for the same tablet strength to meet therapeutic or prophylactic goals. The elemental iron component itself is available in other formulations and strengths (like liquid drops or different tablet strengths) across the broader market, depending on the specific brand.

Q: What does 'bioavailability' mean for a drug like Ферроплекс?

Bioavailability is a term used to describe the degree to which an ingredient is absorbed into the body and becomes available to have its intended effect. The formulation of Ферроплекс includes Ascorbic acid as a specific feature designed to enhance the bioavailability of the iron component.

Q: Can someone who is vegetarian or vegan use Ферроплекс?

The active ingredients, Ferrous sulfate and Ascorbic acid, are both synthetic and chemically synthesized. Suitability for vegetarian or vegan diets, however, depends on the source and nature of the inactive ingredients (excipients) used in the tablet coating and core, which are listed in the official product label.

Q: Is there any information about using Ферроплекс with thyroid medication?

Yes, regulatory documents list Thyroid Hormones (such as levothyroxine) as medications that require caution. Iron supplements can decrease the absorption of these hormones, and Official information recommends separating administration from thyroid hormones by at least two hours.

Advertisements

How should Ферроплекс be stored and disposed of?

How to Store and Dispose of Ферроплекс (Ferroplex)

The storage and disposal of this medicine are governed by official regulatory instructions to maintain product quality and safety.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at a temperature that does not exceed 25 C
Protection Keep in the original container and tightly closed; protect from light and moisture.
Child Safety Must be kept out of the sight and reach of children due to the risk of fatal iron overdose.

Disposal Guidelines

  • Unused or expired Ферроплекс must not be disposed of using household waste or wastewater (e.g., flushing down the toilet).
  • The product should be returned to a pharmacy or an authorized disposal service to ensure safe and compliant destruction, in accordance with local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ферроплекс found in:

A-Z Index: